
Low-Level Contaminants in Pharmaceuticals: Navigating Risk, Regulation, and Detection Strategies
Low-Level Contaminants in Pharmaceuticals: Navigating Risk, Regulation, and Detection Strategies The pharmaceutical industry is under unprecedented scrutiny as regulators tighten restrictions on trace-level impurities in drug products. From nitrosamines to heavy metals and residual solvents, low-level contaminants have become a focal point of regulatory action and a source of concern








